vimarsana.com

Page 152 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Cold Storage Construction Market Report 2020: Market to Reach $19 Billion by 2027 - Vaccines Make Cold Chain Highly Relevant in Pharmaceutical Logistics

Share this article Share this article ResearchAndMarkets.com s offering. Global Cold Storage Construction Market to Reach $19 Billion by 2027 Amid the COVID-19 crisis, the global market for Cold Storage Construction estimated at US$7.9 Billion in the year 2020, is projected to reach a revised size of US$19 Billion by 2027, growing at a CAGR of 13.4% over the analysis period 2020-2027. Production Stores, one of the segments analyzed in the report, is projected to record a 13.6% CAGR and reach US$11.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bulk Stores segment is readjusted to a revised 13.1% CAGR for the next 7-year period.

Breckenridge Announces Final Approval of its ANDA for Asenapine Sublingual Tablets, 5 mg Strength (generic for Saphris®)

Breckenridge Announces Final Approval of its ANDA for Asenapine Sublingual Tablets, 5 mg Strength (generic for Saphris®) News provided by Share this article Share this article BERLIN, Conn., March 8, 2021 /PRNewswire/ Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted final approval of its Abbreviated New Drug Application for Asenapine Sublingual Tablets in 5mg strength (generic for Saphris ®). Breckenridge plans to launch this strength immediately. Breckenridge previously launched the product s 2.5mg and 10mg strengths and will now market all three strengths. This product was developed in collaboration with MSN Laboratories Private Limited. According to industry sales data, Saphris

Miravo Healthcare™ Files Preliminary Base Shelf Prospectus

L7 Informatics Raises $13M in Series B Financing

L7 Informatics Raises $13M in Series B Financing News provided by Share this article Share this article AUSTIN, Texas, March 8, 2021 /PRNewswire/ L7 Informatics, a leader in enterprise-scale digital transformation and automation of scientific processes in the life sciences and healthcare domains, announced that it closed its Series B financing round. The financing was supported by previous investors along with several new investors, including Phoenix Venture Partners. We are very excited to join the L7 mission. The company s Enterprise Science Platform has the core flexibility and breadth needed to advance healthcare and life sciences R&D and manufacturing into a new digital age,  said Dr. Zach Jonasson, Managing Partner of Phoenix Venture Partners. 

Kansas Cardiologist Improves the Stress Test Experience for Women

Kansas Cardiologist Improves the Stress Test Experience for Women News provided by Share this article Share this article KANSAS CITY, Kan., March 8, 2021 /PRNewswire/  University of Kansas Health System Cardiologist Ashley Simmons knew there could and should be a better way to measure female heart function. She d seen countless women balk at the uncomfortable testing that requires patients to go bra-less. She d also seen many Cardiac Sonographers struggle to place the precordial ECG leads appropriately and has even seen the leads fall off due to basic breast motion. CardioBra is a two-part system, uniquely designed to work with CLARAVUEⓇ electrodes by Nissha Medical Technologies. CardioBra used with CLARAVUEⓇ reinforces electrode adherence and promotes ECG lead placement under the breast with added support. CLARAVUEⓇ’s low-profile pre-wired design eliminates the pinch clips allowing for a comfortable fit.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.